Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
23 Aug 2019
Change (% chg)

$-0.01 (-1.61%)
Prev Close
$0.39
Open
$0.38
Day's High
$0.39
Day's Low
$0.37
Volume
40,861
Avg. Vol
121,859
52-wk High
$2.60
52-wk Low
$0.36

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: 0.05
Market Cap(Mil.): $35.73
Shares Outstanding(Mil.): 79.41
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.11 -- --
ROI: -22.11 7.52 12.69
ROE: -46.61 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates